Inspire Medical Systems/$INSP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Inspire Medical Systems
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Ticker
$INSP
Sector
Primary listing
NYSE
Employees
1,333
Headquarters
Website
INSP Metrics
BasicAdvanced
$1.6B
11.18
$4.89
0.72
-
Price and volume
Market cap
$1.6B
Beta
0.72
52-week high
$172.95
52-week low
$53.11
Average daily volume
1.3M
Financial strength
Current ratio
6.076
Quick ratio
4.455
Long term debt to equity
3.84
Total debt to equity
3.84
Interest coverage (TTM)
371.93%
Profitability
EBITDA (TTM)
64.911
Gross margin (TTM)
85.39%
Net profit margin (TTM)
15.95%
Operating margin (TTM)
5.59%
Effective tax rate (TTM)
-121.35%
Revenue per employee (TTM)
$680,000
Management effectiveness
Return on assets (TTM)
3.71%
Return on equity (TTM)
19.77%
Valuation
Price to earnings (TTM)
11.182
Price to revenue (TTM)
1.761
Price to book
2
Price to tangible book (TTM)
2
Price to free cash flow (TTM)
20.463
Free cash flow yield (TTM)
4.89%
Free cash flow per share (TTM)
2.672
Growth
Revenue change (TTM)
13.60%
Earnings per share change (TTM)
179.43%
3-year revenue growth (CAGR)
30.77%
10-year revenue growth (CAGR)
60.56%
3-year earnings per share growth (CAGR)
45.12%
10-year earnings per share growth (CAGR)
-13.46%
What the Analysts think about INSP
Analyst ratings (Buy, Hold, Sell) for Inspire Medical Systems stock.
INSP Financial Performance
Revenues and expenses
INSP Earnings Performance
Company profitability
INSP News
AllArticlesVideos
Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP
Business Wire·3 weeks ago
Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP
Business Wire·2 months ago
The Law Offices of Frank R. Cruz Announces Investigation of Inspire Medical Systems, Inc. (INSP) on Behalf of Investors
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Inspire Medical Systems stock?
Inspire Medical Systems (INSP) has a market cap of $1.6B as of March 20, 2026.
What is the P/E ratio for Inspire Medical Systems stock?
The price to earnings (P/E) ratio for Inspire Medical Systems (INSP) stock is 11.18 as of March 20, 2026.
Does Inspire Medical Systems stock pay dividends?
No, Inspire Medical Systems (INSP) stock does not pay dividends to its shareholders as of March 20, 2026.
When is the next Inspire Medical Systems dividend payment date?
Inspire Medical Systems (INSP) stock does not pay dividends to its shareholders.
What is the beta indicator for Inspire Medical Systems?
Inspire Medical Systems (INSP) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.